Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT05608642

Intravenous Treatments Used in Medication Overuse Headache Bridge Treatment

Conditions: Medication Overuse Headache

Sex: All
Ages: 18 Years – 65 Years
Phase: NA
Enrollment: 45
Sponsor: Diskapi Teaching and Research Hospital

Location: Turkey

Summary

Medication overuse headache is the chronicity of headaches, which occurs more than 15 days a month, as a result of frequent use of painkillers, opioids or migraine attack drugs (ergotamine, triptan) in individuals with pre-existing primary headache disease.In the treatment of this headache, two ways can be followed as slow drug discontinuation or sudden drug discontinuation. The most commonly used method is the sudden discontinuation of the overused analgesic agent, the initiation of prophylactic treatment, and then the application of bridge therapy for 6-10 days. Intravenous hydration, steroids, antiemetics, neuroleptic drugs and local anesthetic drugs such as lidocaine can be used in bridge treatment.

Eligibility Criteria

Inclusion Criteria:Medication overuse headacheChronic migraineExclusion Criteria:Other headaches will not accompany (tension-type headache, cluster...)PregnancyEpilepsiaHeart diseaseBradikardiaHypertensionDiabetes mellitus

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05608642). StuddyBuddy aggregates publicly available trial information.